Canada markets closed

Valbiotis SA (ALVAL.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
4.1100+0.1700 (+4.31%)
At close: 05:35PM CEST

Valbiotis SA

rue Paul Vatine
12th Floor ZI des Quatre Chevaliers
Périgny 17180
France
33 5 46 28 62 58
https://www.valbiotis.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

NameTitlePayExercisedYear Born
Mr. Sebastien Peltier HDR, Ph.D.Co-Founder, Member of the Management Board & CEO318kN/A1978
Mr. Sebastien BessyCOO & Member of the Management Board213kN/AN/A
Mr. Pascal Sirvent Ph.D.CSO & Member of the Management Board241kN/AN/A
Ms. Murielle CazaubielCMO & Member of the Management Board205kN/AN/A
Mr. Stanislas SordetCFO & Member of Management BoardN/AN/AN/A
Ms. Charlotte JezequelCPO & Member of Management BoardN/AN/AN/A
Dr. Josep InfestaHead of Global Business DevelopmentN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Valbiotis SA engages in the research and development of health nutrition products to prevent and control metabolic and cardiovascular diseases in France. The company develops TOTUM-63 for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II/III clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with MASLD. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.

Corporate Governance

Valbiotis SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.